ScreenerHero

NVOSNovo Integrated Sciences, Inc.

NAS · US · Healthcare · Medical Care Facilities · novointegrated.com
0.0006USD0.00%Mkt Cap: 11838 $P/E: —

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product S…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$95.21BUSDP/E 14.4
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$22.61BUSDP/E 10.9
FME
Fresenius Medical Care AG & Co. KGaA
$11.72BUSDP/E 12.1
FMS
Fresenius Medical Care AG & Co. KGaA
$12.47BUSDP/E 12.2
EHC
Encompass Health Corporation
$11.87BUSDP/E 20.1
DVA
DaVita Inc.
$11.16BUSDP/E 14.7
ENSG
The Ensign Group, Inc.
$10.46BUSDP/E 28.1
UHS
Universal Health Services, Inc. Class B
$10.45BUSDP/E 7.2
CHE
Chemed Corporation
$7.07BUSDP/E 27.2
PACS
PACS Group Inc.
$7.00BUSDP/E 25.9
LFST
LifeStance Health Group Inc. Common Stock
$4.76BUSDP/E 95.9
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.46BUSDP/E 22.6
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.66BUSDP/E 26.2
OPCH
Option Care Health, Inc.
$3.55BUSDP/E 18.0
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.3
BKD
Brookdale Senior Living Inc.
$2.82BUSD
EMEIS
Emeis SA
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.59BUSD

Key Statistics

Company
Market Cap11.84K $
Enterprise Value4.87M $
Revenue (TTM)13.29M $
Gross Profit4.95M $
Net Income (TTM)-13.21M $
Revenue/Share0.7370 USD
Last Price0.0006 USD
Fiscal Year EndAug 2024
MR QuarterAug 2024
Employees115
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.80
EV/Revenue0.37
P/S0.00
P/B0.00
EPS (TTM)-0.73
EPS (Forward)—
52W Range
0.00011% of range0.0600
52W High0.0600 USD
52W Low0.0001 USD
Profitability
Gross Margin39.39%
Oper. Margin-30.39%
EBITDA Margin-45.53%
Profit Margin-105.11%
ROE-53.25%
ROA-37.16%
Growth
Revenue Growth-6.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.24M $
CapEx (TTM)49.22K $
FCF Margin36.27%
FCF Yield40735.46%
Net Debt5.14M $
Net Debt/EBITDA-0.85
Balance Sheet
Debt/Equity0.18
Current Ratio0.37
Quick Ratio0.19
Book Value/Sh0.7820 USD
Cash/Share0.0430 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 1, 2021
Splits
Last Split1:10
Split DateNov 7, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.19.73M
Float18.43M
Insiders6.59%
Institutions0.00%
Short Interest
Short Ratio1.1d
Short % Float1.45%
Short % Out.1.44%
Shares Short274.86K
Short (prev mo.)710.65K
Technical
SMA 500.0031 (-80.8%)
SMA 2000.0040 (-85.1%)
Beta6.00
S&P 52W Chg18.16%
Avg Vol (30d)2.34K
Avg Vol (10d)305
Technical Indicators
RSI (14)38.9
MACD-0.0007
MACD Signal-0.0005
MACD Hist.-0.0002
BB Upper0.0054 USD
BB Middle0.0029 USD
BB Lower0.0004 USD
BB Width170.45%
ATR (14)0.0011 USD
Vol Ratio (20d)0.38x